Literature DB >> 27040854

Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature.

Bradford J Siegele1, Konstantin Shilo2, Bo H Chao2, David P Carbone2, Weiqiang Zhao2, Olga Ioffe3, Wilbur A Franklin1, Martin J Edelman3, Dara L Aisner4.   

Abstract

Activating mutations in the epidermal growth factor receptor (EGFR) gene are exceedingly rare in small cell lung cancer (SCLC). We present two cases of SCLC harboring EGFR mutations, one in an 82 year-old male smoker with a combined SCLC and adenocarcinoma with a novel D855H point mutation in exon 21, and the second in a 68 year-old female never smoker with the L858R point mutation in exon 21. The cases, accompanied by a review of the literature, highlight the importance of integration of clinicopathologic considerations and adherence to recently promulgated Guideline recommendations for molecular testing in lung cancer.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; EGFR; Guideline; Molecular; Pathology; SCLC

Mesh:

Substances:

Year:  2016        PMID: 27040854      PMCID: PMC5524560          DOI: 10.1016/j.lungcan.2016.02.012

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  37 in total

1.  Small cell lung cancer with an epidermal growth factor receptor mutation in primary gefitinib-resistant adenocarcinoma of the lung.

Authors:  Ada T W Ma; Wai Kong Chan; Edmond S K Ma; Thomas Cheng; Paul N M Cheng
Journal:  Acta Oncol       Date:  2011-11-30       Impact factor: 4.089

2.  Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer.

Authors:  Meng-Heng Hsieh; Yueh-Fu Fang; Wen-Cheng Chang; Han-Pin Kuo; Shinn-Yn Lin; Hui-Ping Liu; Chih-Lin Liu; Hsiu-Chi Chen; Yuan-Chieh Ku; Ya-Ting Chen; Ya-Hui Chang; Ying-Tsong Chen; Bae-Li Hsi; Shih-Feng Tsai; Shiu-Feng Huang
Journal:  Lung Cancer       Date:  2006-07-25       Impact factor: 5.705

3.  Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.

Authors:  Emma Norkowski; Maria-Rosa Ghigna; Ludovic Lacroix; Thierry Le Chevalier; Élie Fadel; Philippe Dartevelle; Peter Dorfmuller; Vincent Thomas de Montpréville
Journal:  J Thorac Oncol       Date:  2013-10       Impact factor: 15.609

4.  Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma.

Authors:  Satoshi Watanabe; Takashi Sone; Tomoharu Matsui; Kenta Yamamura; Mayuko Tani; Akihito Okazaki; Koji Kurokawa; Yuichi Tambo; Hazuki Takato; Noriyuki Ohkura; Yuko Waseda; Nobuyuki Katayama; Kazuo Kasahara
Journal:  Lung Cancer       Date:  2013-09-05       Impact factor: 5.705

5.  Rapid and accurate ranking of binding affinities of epidermal growth factor receptor sequences with selected lung cancer drugs.

Authors:  Shunzhou Wan; Peter V Coveney
Journal:  J R Soc Interface       Date:  2011-01-12       Impact factor: 4.118

6.  Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with gefitinib-responsive adenocarcinoma of the lung.

Authors:  Naheed Alam; Karen S Gustafson; Marc Ladanyi; Maureen F Zakowski; Atul Kapoor; Alexander M Truskinovsky; Arkadiusz Z Dudek
Journal:  Clin Lung Cancer       Date:  2010-09-01       Impact factor: 4.785

7.  Identifying EGFR mutations from SCLC patient plasma by mutant-enriched liquidchip technology.

Authors:  Hong-Yang Lu; Zhen-Yi Lu; Qiao-Yuan Cheng; Ju-Fen Cai; Xiao-Jia Wang; Yi-Ping Zhang; Cai-Jin Lou; Xin-Min Yu; Jing Qin; Wei-Wu Ye; Lei Lei; Jian Huang; Hui-Yi Yang; Wei-Min Mao
Journal:  Adv Clin Exp Med       Date:  2014 Mar-Apr       Impact factor: 1.727

8.  Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.

Authors:  Martin Peifer; Lynnette Fernández-Cuesta; Martin L Sos; Julie George; Danila Seidel; Lawryn H Kasper; Dennis Plenker; Frauke Leenders; Ruping Sun; Thomas Zander; Roopika Menon; Mirjam Koker; Ilona Dahmen; Christian Müller; Vincenzo Di Cerbo; Hans-Ulrich Schildhaus; Janine Altmüller; Ingelore Baessmann; Christian Becker; Bram de Wilde; Jo Vandesompele; Diana Böhm; Sascha Ansén; Franziska Gabler; Ines Wilkening; Stefanie Heynck; Johannes M Heuckmann; Xin Lu; Scott L Carter; Kristian Cibulskis; Shantanu Banerji; Gad Getz; Kwon-Sik Park; Daniel Rauh; Christian Grütter; Matthias Fischer; Laura Pasqualucci; Gavin Wright; Zoe Wainer; Prudence Russell; Iver Petersen; Yuan Chen; Erich Stoelben; Corinna Ludwig; Philipp Schnabel; Hans Hoffmann; Thomas Muley; Michael Brockmann; Walburga Engel-Riedel; Lucia A Muscarella; Vito M Fazio; Harry Groen; Wim Timens; Hannie Sietsma; Erik Thunnissen; Egbert Smit; Daniëlle A M Heideman; Peter J F Snijders; Federico Cappuzzo; Claudia Ligorio; Stefania Damiani; John Field; Steinar Solberg; Odd Terje Brustugun; Marius Lund-Iversen; Jörg Sänger; Joachim H Clement; Alex Soltermann; Holger Moch; Walter Weder; Benjamin Solomon; Jean-Charles Soria; Pierre Validire; Benjamin Besse; Elisabeth Brambilla; Christian Brambilla; Sylvie Lantuejoul; Philippe Lorimier; Peter M Schneider; Michael Hallek; William Pao; Matthew Meyerson; Julien Sage; Jay Shendure; Robert Schneider; Reinhard Büttner; Jürgen Wolf; Peter Nürnberg; Sven Perner; Lukas C Heukamp; Paul K Brindle; Stefan Haas; Roman K Thomas
Journal:  Nat Genet       Date:  2012-09-02       Impact factor: 38.330

9.  Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation.

Authors:  Ryotaro Morinaga; Isamu Okamoto; Kazuyuki Furuta; Yukiko Kawano; Masaru Sekijima; Kensaku Dote; Takao Satou; Kazuto Nishio; Masahiro Fukuoka; Kazuhiko Nakagawa
Journal:  Lung Cancer       Date:  2007-06-29       Impact factor: 5.705

10.  Small-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing "wax-and-wane" transformation.

Authors:  Yusuke Takagi; Yoshiro Nakahara; Yukio Hosomi; Tsunekazu Hishima
Journal:  BMC Cancer       Date:  2013-11-07       Impact factor: 4.430

View more
  7 in total

1.  Successful treatment with an EGFR tyrosine kinase inhibitor Afatinib in a patient with combined small-cell lung Cancer with EGFR mutation.

Authors:  Midori Tanaka; Hidenobu Ishii; Hayato Moribuchi; Yoshiko Naito; Norikazu Matsuo; Masayuki Nakamura; Takaaki Tokito; Koichi Azuma; Kazuhiko Yamada; Tomoaki Hoshino
Journal:  Invest New Drugs       Date:  2018-03-15       Impact factor: 3.850

Review 2.  Molecular diagnostics of lung cancer in the clinic.

Authors:  Lynette Sholl
Journal:  Transl Lung Cancer Res       Date:  2017-10

Review 3.  Combined small-cell lung carcinoma.

Authors:  Jing Qin; Hongyang Lu
Journal:  Onco Targets Ther       Date:  2018-06-19       Impact factor: 4.147

Review 4.  Pathological transition as the arising mechanism for drug resistance in lung cancer.

Authors:  Yueqing Chen; Waiying Yvonne Tang; Xinyuan Tong; Hongbin Ji
Journal:  Cancer Commun (Lond)       Date:  2019-10-01

Review 5.  [MDT Treatment of Small Cell Lung Cancer Complicated with Adenocarcinoma: 
A Case Report and Literature Review].

Authors:  Zihan Qu; Jiewei Liu; Feng Luo; Lu Li; Lingling Zhu; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-11-20

6.  Multi-channel multi-task deep learning for predicting EGFR and KRAS mutations of non-small cell lung cancer on CT images.

Authors:  Yunyun Dong; Lina Hou; Wenkai Yang; Jiahao Han; Jiawen Wang; Yan Qiang; Juanjuan Zhao; Jiaxin Hou; Kai Song; Yulan Ma; Ntikurako Guy Fernand Kazihise; Yanfen Cui; Xiaotang Yang
Journal:  Quant Imaging Med Surg       Date:  2021-06

7.  Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature review.

Authors:  Takayuki Niitsu; Takayuki Shiroyama; Kotaro Miyake; Yoshimi Noda; Kansuke Kido; Reina Hara; Takatoshi Enomoto; Yuichi Adachi; Saori Amiya; Yasuhiko Suga; Kiyoharu Fukushima; Shohei Koyama; Kota Iwahori; Haruhiko Hirata; Izumi Nagatomo; Yoshito Takeda; Atsushi Kumanogoh
Journal:  Thorac Cancer       Date:  2020-10-25       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.